Optiray 350 Prefilled Syringe 50ml Singapore - English - HSA (Health Sciences Authority)

optiray 350 prefilled syringe 50ml

transmedic pte ltd - ioversol - injection, solution - 741 mg/ml - ioversol 741 mg/ml

OPTIRAY 350 INJECTION 74% Singapore - English - HSA (Health Sciences Authority)

optiray 350 injection 74%

transmedic pte ltd - ioversol - injection - 741 mg/ml - ioversol 741 mg/ml

CONRAY 30 SOLUTION Canada - English - Health Canada

conray 30 solution

liebel-flarsheim canada inc - iothalamate meglumine - solution - 300mg - iothalamate meglumine 300mg - roentgenography

CONRAY 43 SOLUTION Canada - English - Health Canada

conray 43 solution

liebel-flarsheim canada inc - iothalamate meglumine - solution - 430mg - iothalamate meglumine 430mg - roentgenography

Gastrografin Oral Liquid Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

gastrografin oral liquid bottle

bayer australia ltd - amidotrizoate meglumine, quantity: 660 mg/ml; sodium amidotrizoate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: disodium edetate; anise oil; polysorbate 80; saccharin; purified water - gastrografin is a contrast medium for examination of the gastrointestinal tract. it can be administered orally and as enema and is primarily indicated in cases in which the use barium sulfate is unsatisfactory, undesirable or contraindicated. among these are: - suspected partial or complete stenosis - acute haemorrhage - threatening perforation (peptic ulcer, diverticulum) - other acute conditions which are likely to require surgery - after resection of the stomach or the intestine (danger of perforation or leak) - megacolon - visualisation of a foreign body or tumour before endoscopy - visualisation of gastrointestinal fistula. in addition to these conditions gastrografin can generally be used for the same purposes as barium sulfate with the exception of the visualisation of mucosal diseases. due to the insufficient coating properties of gastrografin, barium sulfate should be used for single or double contrast techniques. in combination with barium sulfate, gastrografin has considerably improved routine inve

DBL™ Promethazine hydrochloride New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ promethazine hydrochloride

pfizer new zealand limited - promethazine hydrochloride 25 mg/ml - solution for injection - 50 mg/2ml - active: promethazine hydrochloride 25 mg/ml excipient: glacial acetic acid sodium acetate trihydrate sodium edetate sodium metabisulfite water for injection - dbl™ promethazine hydrochloride injection bp is indicated for the following conditions: treatment of allergic reactions such as: uncomplicated allergic conditions of the immediate type, eg. pruritus, urticaria and angioedema, when oraltherapy is impossible or contraindicated treatment and prevention of vomiting including: motion sickness; drug induced nausea; prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery, such as procedures with a high incidence of postoperative vomiting (eg. gynaecological surgery, strabismus or middle ear surgery, and electroconvulsive therapy); in patients with a past history of motion sickness or post operative vomiting; and in patients in whom avoidance of vomiting is crucial (eg. neurosurgery and eye surgery); promethazine has sedative effects and it is also used in: preoperative, postoperative and obstetric (during labour) sedation.